论文部分内容阅读
美国Ｐｈａｒｍａｃｙｃｌｉｃｓ公司最近报道了几种产品的研究进展。其中之一是辐射敏化剂Ｘｃｙｔｒｉｎ（ｇａｄｏｌｉｎｉｕｍｔｅｘａｐｈｙｒｉｎ），另一种为光血管成形术剂Ａｎｔｒｉｎ。两者都能选择性地蓄积在病变部位（肿瘤或动脉斑），而当受射线或光活化时就能有
The United States Pharmacyclics Company recently reported the research progress of several products. One of these is the radiosensitizer Xcytrin (gadoliniumtexaphyrin) and the other is the optical angioplastient Antrin. Both accumulate selectively in diseased sites (tumors or plaque), and when irradiated or activated by light